These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8261578

  • 1. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
    Maehara Y, Inutsuka S, Takeuchi H, Baba H, Kusumoto H, Sugimachi K.
    Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
    [Abstract] [Full Text] [Related]

  • 2. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
    Imaizumi M, Kondo T, Kamei H, Ichihashi H.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
    [Abstract] [Full Text] [Related]

  • 3. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
    Kondo T, Sakamoto J, Nakazato H.
    Biotherapy; 1991 Dec; 3(4):287-95. PubMed ID: 1786194
    [Abstract] [Full Text] [Related]

  • 4. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
    Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, Anai H, Maehara Y, Sugimachi K.
    Anticancer Res; 1992 Dec; 12(3):645-8. PubMed ID: 1622120
    [Abstract] [Full Text] [Related]

  • 5. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H, Muguruma K, Ohira M, Kubo N, Yamashita Y, Maeda K, Sawada T, Hirakawa K.
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of postoperative immunochemotherapy in lung cancer].
    Ikeda T, Sakai T, Suito T, Kosaki G.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
    [Abstract] [Full Text] [Related]

  • 7. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
    Maehara Y, Okuyama T, Kakeji Y, Baba H, Furusawa M, Sugimachi K.
    Am J Surg; 1994 Jul; 168(1):36-40. PubMed ID: 8024097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Ichihashi H, Kondo T, Nakazato H.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J.
    Lancet; 1994 May 07; 343(8906):1122-6. PubMed ID: 7910230
    [Abstract] [Full Text] [Related]

  • 14. [Immunochemotherapy for cancer patients of the stomach--cancer therapy keeping with good host-immunocompetency].
    Saji S, Kunieda K, Sugiyama Y.
    Nihon Rinsho; 2001 Apr 07; 59 Suppl 4():420-6. PubMed ID: 11424418
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
    Kanabe S, Tamakuma S, Mimura K, Hiraide H, Mochizuki H, Tamaki K, Kurokawa T, Kadota T, Hatsuse K, Kawano M.
    Gan No Rinsho; 1985 Nov 07; 31(14):1805-9. PubMed ID: 3936946
    [Abstract] [Full Text] [Related]

  • 16. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
    Nakajima T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondou T, Abe O, Kikuchi K, Tanabe T, Ogawa N.
    Gan To Kagaku Ryoho; 1989 Apr 07; 16(4 Pt 1):799-806. PubMed ID: 2496668
    [Abstract] [Full Text] [Related]

  • 17. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
    Nakajima T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Abe O, Kikuchi K, Tanabe T, Ogawa N.
    Gan To Kagaku Ryoho; 1985 Sep 07; 12(9):1850-63. PubMed ID: 3929694
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials.
    Sakamoto J, Teramukai S, Nakazato H, Sato Y, Uchino J, Taguchi T, Ryoma Y, Ohashi Y.
    J Immunother; 2002 Sep 07; 25(5):405-12. PubMed ID: 12218778
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of postoperative immunochemotherapy of lung cancer].
    Ikeda T, Sakai T, Suito T, Kosaki G.
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Jan 07; 35(1):1-4. PubMed ID: 3572111
    [No Abstract] [Full Text] [Related]

  • 20. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
    Tamada R, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Abe O, Kikuchi K, Tanabe T, Nakajima T.
    Gan To Kagaku Ryoho; 1987 Mar 07; 14(3 Pt 1):716-22. PubMed ID: 3103540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.